TITLE:
Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease

CONDITION:
Alzheimer's Disease

INTERVENTION:
LY451395

SUMMARY:

      Study of an investigational medication for the treatment of Alzheimer's Disease in patients
      who are not taking Aricept, Reminyl, Exelon.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 50 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Must have a clinical diagnosis of Alzheimer's Disease

          -  Must be at least 50 years of age

          -  Must fluently read and speak English

          -  Must have a reliable caregiver

        Exclusion Criteria:

          -  Has serious health problems other than Alzheimer's Disease

          -  Cannot swallow whole pills

          -  Has had a menstrual period in the last two years

          -  Takes insulin for diabetes

          -  Has taken Aricept, Reminyl, or Exelon in the last 5 weeks
      
